BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30145982)

  • 1. Chordoma: a case series and review of the literature.
    Alan O; Akin Telli T; Ercelep O; Tanrikulu Simsek E; Basoglu Tuylu T; Mutis A; Hasanov R; Kaya S; Akgül Babacan N; Dane F; Yumuk PF
    J Med Case Rep; 2018 Aug; 12(1):239. PubMed ID: 30145982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chordoma.
    Casali PG; Stacchiotti S; Sangalli C; Olmi P; Gronchi A
    Curr Opin Oncol; 2007 Jul; 19(4):367-70. PubMed ID: 17545801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).
    Lebellec L; Chauffert B; Blay JY; Le Cesne A; Chevreau C; Bompas E; Bertucci F; Cupissol D; Fabbro M; Saada-Bouzid E; Duffaud F; Feuvret L; Bonneville-Levard A; Bay JO; Vauleon E; Vinceneux A; Noel G; Penel N; Mir O
    Eur J Cancer; 2017 Jul; 79():119-128. PubMed ID: 28478340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular targeted therapies in advanced or metastatic chordoma patients: facts and hypotheses.
    Lebellec L; Aubert S; Zaïri F; Ryckewaert T; Chauffert B; Penel N
    Crit Rev Oncol Hematol; 2015 Jul; 95(1):125-31. PubMed ID: 25682222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review.
    Launay SG; Chetaille B; Medina F; Perrot D; Nazarian S; Guiramand J; Moureau-Zabotto L; Bertucci F
    BMC Cancer; 2011 Oct; 11():423. PubMed ID: 21970335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic Body Radiation Therapy for Patients With Sacral Chordoma Who Previously Received Carbon Ion Therapy.
    Ito K; Ogawa H
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1263-1264. PubMed ID: 34273319
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of pazopanib and sunitinib in advanced axial chordoma: a single reference centre case series.
    Lipplaa A; Dijkstra S; Gelderblom H
    Clin Sarcoma Res; 2016; 6():19. PubMed ID: 27822356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study.
    Stacchiotti S; Morosi C; Lo Vullo S; Casale A; Palassini E; Frezza AM; Dinoi G; Messina A; Gronchi A; Cavalleri A; Venturelli E; Morelli D; Pilotti S; Collini P; Brich S; Tamborini E; Mariani L; Casali PG
    Cancer; 2018 Oct; 124(20):4056-4063. PubMed ID: 30216418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dedifferentiated chordoma of the skull base. A case report].
    Sefiani S; Amarti A; Maher M; Benkiran L; Saidi A
    Neurochirurgie; 2002 Nov; 48(5):436-9. PubMed ID: 12483123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small prospective study of chordomas treated with radiotherapy and razoxane.
    Rhomberg W; Böhler FK; Novak H; Dertinger S; Breitfellner G
    Strahlenther Onkol; 2003 Apr; 179(4):249-53. PubMed ID: 12707714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to imatinib plus sirolimus in advanced chordoma.
    Stacchiotti S; Marrari A; Tamborini E; Palassini E; Virdis E; Messina A; Crippa F; Morosi C; Gronchi A; Pilotti S; Casali PG
    Ann Oncol; 2009 Nov; 20(11):1886-94. PubMed ID: 19570961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose radiotherapy in the management of chordoma and chondrosarcoma of the skull base and cervical spine: Part 1--Clinical outcomes.
    Foweraker KL; Burton KE; Maynard SE; Jena R; Jefferies SJ; Laing RJ; Burnet NG
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):509-16. PubMed ID: 17524633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history and surgical treatment of chordoma: a retrospective cohort study.
    Aguiar Júnior S; Andrade WP; Baiocchi G; Guimarães GC; Cunha IW; Estrada DA; Suzuki SH; Kowalski LP; Lopes A
    Sao Paulo Med J; 2014; 132(5):297-302. PubMed ID: 25075583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas.
    Casali PG; Le Cesne A; Poveda Velasco A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom H; Adenis A; Hartmann JT; Duffaud F; Goldstein D; Broto JM; Gronchi A; Dei Tos AP; Marréaud S; van der Graaf WT; Zalcberg JR; Litière S; Blay JY
    J Clin Oncol; 2015 Dec; 33(36):4276-83. PubMed ID: 26573069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypofractionated stereotactic radiation therapy for skull base and upper cervical chordoma and chondrosarcoma: preliminary results.
    Gwak HS; Yoo HJ; Youn SM; Chang U; Lee DH; Yoo SY; Rhee CH
    Stereotact Funct Neurosurg; 2005; 83(5-6):233-43. PubMed ID: 16601376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma.
    Hof H; Welzel T; Debus J
    Onkologie; 2006 Dec; 29(12):572-4. PubMed ID: 17202828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clival chordoma: a single-centre outcome analysis.
    Jägersberg M; El Rahal A; Dammann P; Merkler D; Weber DC; Schaller K
    Acta Neurochir (Wien); 2017 Oct; 159(10):1815-1823. PubMed ID: 28478512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy for chordomas of the base of skull and cervical spine: patterns of failure and outcome after relapse.
    Fagundes MA; Hug EB; Liebsch NJ; Daly W; Efird J; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):579-84. PubMed ID: 7558946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chordoma in paranasal sinuses.
    Tabrizi R; Rakee M; Ozkan BT; Noori R; Azarpira N; Mohammedinejhad C
    J Craniofac Surg; 2009 Jul; 20(4):1272-5. PubMed ID: 19625846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Auto-immune thyroid dysfunction induced by tyrosine kinase inhibitors in a patient with recurrent chordoma.
    Eroukhmanoff J; Castinetti F; Penel N; Salas S
    BMC Cancer; 2016 Aug; 16(1):679. PubMed ID: 27558389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.